Brazil
Deep-built7% circumcision prevalence
Prevalence of non-therapeutic male circumcision.
Research coverage
A transparent snapshot of what this file currently contains.
8
Sources · Citations
7
Verifications · Independent
5
Structured claims · Evidence-based
Jul 9, 2026
Last updated · deep-built
Research note: Brazil built out as a Phase 2 large-population low-prevalence burst (Jun 2026): closed H1 (write-up), L1/L3/L4 (curated legal) and S1/S2 (8 graded sources #231–238); M2 HIV + profile already present. 5 claims + 2 verified aggregate incidents (SUS deaths + Curitiba reoperations). THE low-prevalence / medical-only + HIV-response-without-VMMC case: circ is rare (~7%), the intact penis is the norm, no continuing religious/cultural tradition; where it happens it is therapeutic, and SUS funds it ONLY for medical indications (668,818 over 1984–2010, Korkes 2012). Brazil's famous HIV response is ART/PrEP/condoms/harm-reduction — NOT VMMC (WHO scopes VMMC to 15 ESA generalized-epidemic countries; Brazil's is concentrated). HONEST-FRAMING: TWO prevalence estimates with scope (~7% small sample vs ~1.3% SUS-medical — NOT merged; recasting 1.3% as overall prevalence was refuted); the 63 SUS deaths (0.013%) are "associated with" admissions, elderly-concentrated, NONE in infants — not botched-baby cases; Curitiba 3.27% is a reoperation rate; VMMC absence framed via WHO scoping not a verbatim protocol claim; "no statute" is a negative finding (PL 790/2011 archived). DEEP_BUILT.
Research claims
Short, testable claims backed by evidence and categorised for clarity.
Circumcision is uncommon in Brazil, with no continuing religious/cultural tradition
Brazil is a low-prevalence country — a commonly-cited ~7% (UNAIDS, from a small 2005 sample) and ~1.3% medically-indicated via the public system (Korkes 2012) — with no continuing religious or cultural mass-circumcision tradition. The intact penis is the norm, and no Latin American country exceeds 20% prevalence.
Two estimates with different scope: the ~7% is a small non-representative sample; the ~1.3% is SUS medical-indication only (not overall prevalence). State both with scope; do not merge.
Brazil has no circumcision statute; its legislative lens treats it as therapy
No Brazilian law restricts non-therapeutic male circumcision of minors. The legislative framing is medical: a proposed bill (PL 790/2011) would have obligated SUS to screen children for phimosis and provide corrective surgery when indicated — it was archived in 2019 without enactment — reflecting that Brazil treats circumcision as a therapeutic intervention, not a routine or cultural practice.
The absence of a restricting statute is a negative finding; PL 790/2011 is a proposed, archived bill, not enacted law.
In Brazil circumcision is a medical procedure the public system funds only when indicated
Where circumcision happens in Brazil it is overwhelmingly therapeutic (phimosis, paraphimosis, balanoposthitis, BXO, preputial neoplasia). The public health system (SUS) performed 668,818 medical circumcisions over 1984–2010 (47.8/100,000 men/year) and funds it only for medical indications — never ritually or prophylactically.
SUS administrative data captures public-system medical procedures only — it excludes private and elective/cosmetic circumcision.
Brazil has a famous HIV response that does not use circumcision
Brazil has a low (~0.4–0.7%), nationally stable, concentrated HIV epidemic and an internationally noted response built on antiretroviral treatment, PrEP (in the public system since 2018), condoms and harm reduction. Voluntary medical male circumcision is not part of it: WHO scopes VMMC to 15 generalized-epidemic priority countries in East/Southern Africa, and Brazil is not among them.
VMMC's absence is established via WHO geographic scoping + the strategy's explicit ART/PrEP emphasis, not a verbatim "not mentioned" claim from the protocol.
Documented Brazilian circumcision harm is medical-procedure complications, not ritual harm
The documented harm in Brazil is clinical: a single Curitiba pediatric centre had a 3.27% reoperation rate (80 of 2,441) for complications such as paraphimosis, bleeding and preputial stenosis, and SUS data recorded 63 deaths "associated with" circumcision admissions over 1992–2010 (0.013%) — concentrated in elderly comorbid patients, with none in infants.
The 63 deaths are "associated with" (during) admissions, not confirmed procedure-caused (DATASUS gives no cause), and are elderly-concentrated, not pediatric botched cases. The 3.27% is a single-centre reoperation rate, not a national complication rate.
Legal status
UnregulatedBrazil has no statute regulating or restricting non-therapeutic male circumcision of minors. Circumcision is treated as a medical procedure: it is uncommon (~7%), the intact penis is the norm, and the public health system (SUS) funds it only for medical indications (phimosis and related conditions), never ritually or prophylactically.
No Brazilian law sets a minimum age for, regulates, or prohibits non-therapeutic male circumcision (a negative finding — none surfaced in research). The legal/policy framing is medical: SUS performs circumcision only for medical indications, and a proposed bill, PL 790/2011, would have obligated SUS to screen children up to age 7 for phimosis and provide corrective surgery (postectomy) when indicated — it was archived in January 2019 and never enacted, but it illustrates that the Brazilian legislative lens treats circumcision as therapy, not routine or cultural practice. There is no religious or prophylactic mass circumcision in the public system. Status UNREGULATED reflects the absence of a restricting statute; the substantive reality is a rare, medically-indicated procedure.
Medical & HIV context
0.7%
Adult HIV prevalence
UNAIDS (2024) · Adults 15–49
rare
Circumcision in newborns
Non-therapeutic (cultural practice)
Childhood (medical, phimosis) + secondary peak after age 60; no infant/rite tradition
Typical age
Benchmarks are international context — not a local complication rate.
Incident registry
No verified incidents are currently recorded for Brazil.
This absence should not be read as proof that harm does not occur — only that no verified, sourced case has been documented in this database yet.